Evidence map›Paper›PMID 39776781›Full record

ArticleAddictive behaviors reports2024

"If I could try it, I'd try it": Qualitative study of the illegal vaping culture in Singapore.

Grace Ping Ping Tan, Xian Zhen Tan, Yvette van der Eijk

Abstract read
In one paragraph

Article in Addictive behaviors reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Grace Ping Ping TanSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
Xian Zhen TanSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
Yvette van der EijkSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims and background: Singapore has one the world's strictest e-cigarette (vaping) regulations, with bans on e-cigarette import, sale, purchase, use and possession. Nevertheless, Singapore is seeing a growing vaping trend. Beyond estimates of vaping prevalence, little is known about vaping in countries where it is banned or the features and drivers of such illegal vaping cultures. This qualitative study thus explored the characteristics of Singapore's illegal vaping culture. Methods: We held ten focus group discussions with 63 Singaporeans aged 21-40 years, exploring participants' experiences and views related to vaping in Singapore. Transcripts of the discussions were coded using deductive and inductive coding methods. Results: Despite its illegal status, vaping was perceived as appealing due to the novelty flavours, ease of use, and convenient access. Harm perceptions were mixed, with concerns over the adverse health impacts along with beliefs that vaping was innocuous when used in moderation. A conspicuous vaping culture among young people, along with perceptions of lax enforcement, drove beliefs that vaping is an entrenched social norm in Singapore. This belief was in turn associated with a sentiment that Singapore should introduce a regulated e-cigarette market to better control its use among the general population. Conclusions: The reinforcement of vaping as a social norm appears to be driving an illegal vaping culture in Singapore. Measures that denormalise vaping could help to strengthen the effectiveness of the vaping ban.

Indexed as

Drug cultureE-cigarettesHarm reductionRegulationTobaccoVaping

Identifiers

PMID39776781
PMCPMC11704964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.